Cargando…
Erratum to “Rapid developability assessments to formulate recombinant protein antigens as stable, low-cost, multi-dose vaccine candidates: Case-study with non-replicating rotavirus (NRRV) vaccine antigens” [J Pharm Sci 110 (2021) 1042–1053]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445825/ https://www.ncbi.nlm.nih.gov/pubmed/33662392 http://dx.doi.org/10.1016/j.xphs.2021.03.003 |
Ejemplares similares
-
Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens
por: Sawant, Nishant, et al.
Publicado: (2021) -
Rational design of heat stable lyophilized rotavirus vaccine formulations
por: Madan, Madhu, et al.
Publicado: (2018) -
Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter
por: Wang, Xiaoqian, et al.
Publicado: (2023) -
Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy
por: Jiang, Xi, et al.
Publicado: (2017) -
Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants
por: Bucardo, Filemón, et al.
Publicado: (2019)